The platelet endothelial cell adhesion molecule‐1 (PECAM1) contributes to endothelial barrier function
- 6 November 1995
- journal article
- Published by Wiley in FEBS Letters
- Vol. 374 (3) , 323-326
- https://doi.org/10.1016/0014-5793(95)01110-z
Abstract
In this study we have analyzed the role of the platelet‐endothelial cell adhesion molecule‐1 (PECAM1) in vascular barrier function. PECAM1 is an immunoglobulin gene superfamily member expressed by endothelial cells at the cell boundaries. Macromolecule permeability assays performed on cell monolayers that express native or transfected PECAM1, indicated that the molecule participates in the establishment and maintenance of vascular barrier function in vitro. This hypothesis was confirmed by the finding that in vivo injection of the specific monoclonal antibody directed against the murine vascular PECAM1 led to a detectable leakage of hepatic and renal blood vessels.Keywords
This publication has 20 references indexed in Scilit:
- Endothelial cells: adhesion and tight junctionsPublished by Elsevier ,2004
- Intracerebral Dialysis and the Blood‐Brain BarrierJournal of Neurochemistry, 1995
- Lymphocyte-Endothelial Cell Adhesion Molecules at the Primary Tumor Site in Human Lung and Renal Cell CarcinomasJNCI Journal of the National Cancer Institute, 1993
- Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.The Journal of cell biology, 1991
- The role of integrins in the maintenance of endothelial monolayer integrity.The Journal of cell biology, 1991
- CADHERINS: A MOLECULAR FAMILY IMPORTANT IN SELECTIVE CELL-CELL ADHESIONAnnual Review of Biochemistry, 1990
- PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene SuperfamilyScience, 1990
- A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions.The Journal of Experimental Medicine, 1989
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.The Journal of Experimental Medicine, 1989
- A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.The Journal of Experimental Medicine, 1987